GHK-Cu (glycyl-L-histidyl-L-lysine copper II) research in Canada takes a deep look at this naturally occurring copper-binding tripeptide and its wide-ranging biological effects. GHK-Cu is found in human plasma, saliva, and urine and declines with age. Canadian skin biology and wound healing researchers study GHK-Cu for its effects on collagen synthesis, matrix metalloproteinase modulation, antioxidant gene expression, and anti-inflammatory signalling — making it one of the most pleiotropic research peptides currently studied.
Collagen Synthesis Research
GHK-Cu stimulates collagen I, III, and VI synthesis in fibroblasts through TGF-beta pathway activation and direct effects on collagen gene transcription. Canadian dermatology researchers study GHK-Cu to understand how copper-peptide complexes modulate extracellular matrix remodelling in wound healing and skin aging models. It also stimulates glycosaminoglycan production and decorin expression, which organize collagen fibril architecture.
Gene Expression Research
Microarray studies have shown GHK-Cu influences the expression of over 4,000 genes in human fibroblasts, including upregulation of antioxidant (SOD1, VEGF) and anti-inflammatory genes, and downregulation of inflammatory genes. Canadian genomics researchers study GHK-Cu to understand how this small tripeptide exerts such broad transcriptional effects.
Sourcing GHK-Cu in Canada
Research-grade GHK-Cu is available in Canada from EhBuddy Peptides. Lab-tested for purity. For laboratory research use only.
GHK-Cu is one of the most pleiotropic and well-studied peptides in Canadian skin biology and wound healing research, offering remarkable breadth of biological activity for a simple tripeptide.
